Adaptive Biotechnologies Corp

+0.29 (+3.44%)
4:01:37 PM EDT: $8.72 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.25B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$38.73 Million
Adjusted EPS-$0.37
See more estimates
10-Day MA$8.29
50-Day MA$8.88
200-Day MA$8.60
See more pivots

Adaptive Biotechnologies Corp Stock, NASDAQ:ADPT

1165 Eastlake Avenue East, Suite 200, Seattle, Washington 98109
United States of America
Phone: +1.206.659.0067
Number of Employees: 790


Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson on September 8, 2009 and is headquartered in Seattle, WA.